AAAAAA

   
Results: 1-10 |
Results: 10
ANASSESSMENT OF THE EFFECT OF ANTI-DRUG ANTIBODY-FORMATION ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF STNFR55-IGG (RO 45-2081-LENERCEPT [LEN]) (S.C.) IN PATIENTS WITH RHEUMATOID-ARTHRITIS (RA)
Authors: KNEER J LEUDIN E LESSLAUER W BIRNBOECK H STEVENS RM
Citation: J. Kneer et al., ANASSESSMENT OF THE EFFECT OF ANTI-DRUG ANTIBODY-FORMATION ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF STNFR55-IGG (RO 45-2081-LENERCEPT [LEN]) (S.C.) IN PATIENTS WITH RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 41(9), 1998, pp. 155-155
IN-VIVO STABLE-ISOTOPE STUDIES IN 3 PATIENTS AFFECTED WITH MITOCHONDRIAL FATTY-ACID OXIDATION DISORDERS - LIMITED DIAGNOSTIC USE OF 1-C-13 FATTY-ACID BREATH TEST USING BOLUS TECHNIQUE
Authors: JAKOBS C KNEER J MARTIN D BOULLOCHE J BRIVET M POLLTHE BT SAUDUBRAY JM
Citation: C. Jakobs et al., IN-VIVO STABLE-ISOTOPE STUDIES IN 3 PATIENTS AFFECTED WITH MITOCHONDRIAL FATTY-ACID OXIDATION DISORDERS - LIMITED DIAGNOSTIC USE OF 1-C-13 FATTY-ACID BREATH TEST USING BOLUS TECHNIQUE, European journal of pediatrics, 156, 1997, pp. 78-82
PROCESSING TOOLS FOR PE-LLD
Authors: KNEER J
Citation: J. Kneer, PROCESSING TOOLS FOR PE-LLD, Kunststoffe, Plast Europe, 86(1), 1996, pp. 80-81
PHARMACOKINETIC-PHARMACODYNAMIC INTERACTIONS BETWEEN 2 SELECTIVE MONOAMINE-OXIDASE INHIBITORS - MOCLOBEMIDE AND SELEGILINE
Authors: DINGEMANSE J KNEER J WALLNOFER A KETTLER R ZURCHER G KOULU M KORN A
Citation: J. Dingemanse et al., PHARMACOKINETIC-PHARMACODYNAMIC INTERACTIONS BETWEEN 2 SELECTIVE MONOAMINE-OXIDASE INHIBITORS - MOCLOBEMIDE AND SELEGILINE, Clinical neuropharmacology, 19(5), 1996, pp. 399-414
INFLUENCE OF MATURATION AND GROWTH ON CEFETAMET PIVOXIL PHARMACOKINETICS - RATIONAL DOSING FOR INFANTS (VOL 40, PG 568, 1996)
Authors: HAYTON WL KNEER J DEGROOT R STOECKEL K
Citation: Wl. Hayton et al., INFLUENCE OF MATURATION AND GROWTH ON CEFETAMET PIVOXIL PHARMACOKINETICS - RATIONAL DOSING FOR INFANTS (VOL 40, PG 568, 1996), Antimicrobial agents and chemotherapy, 40(7), 1996, pp. 1757-1757
INFLUENCE OF MATURATION AND GROWTH ON CEFETAMET PIVOXIL PHARMACOKINETICS, RATIONAL DOSING FOR INFANTS
Authors: HAYTON WL KNEER J DEGROOT R STOECKEL K
Citation: Wl. Hayton et al., INFLUENCE OF MATURATION AND GROWTH ON CEFETAMET PIVOXIL PHARMACOKINETICS, RATIONAL DOSING FOR INFANTS, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 567-574
SAFETY AND EFFICACY OF TNF NEUTRALIZATION BY LENERCEPT (TNFR55-IGG1, RO-45-2081) IN PATIENTS WITH RHEUMATOID-ARTHRITIS EXPOSED TO A SINGLE-DOSE
Authors: HASLER F VANDEPUTTE L DUMONT E KNEER J BOCK J DICKINSON S LESSLAUER W VANDERAUWERA P
Citation: F. Hasler et al., SAFETY AND EFFICACY OF TNF NEUTRALIZATION BY LENERCEPT (TNFR55-IGG1, RO-45-2081) IN PATIENTS WITH RHEUMATOID-ARTHRITIS EXPOSED TO A SINGLE-DOSE, Arthritis and rheumatism, 39(9), 1996, pp. 1291-1291
SWITCH IN TREATMENT FROM TRICYCLIC ANTIDEPRESSANTS TO MOCLOBEMIDE - ANEW-GENERATION MONOAMINE-OXIDASE INHIBITOR
Authors: DINGEMANSE J KNEER J FOTTELER B GROEN H PEETERS PAM JONKMAN JHG
Citation: J. Dingemanse et al., SWITCH IN TREATMENT FROM TRICYCLIC ANTIDEPRESSANTS TO MOCLOBEMIDE - ANEW-GENERATION MONOAMINE-OXIDASE INHIBITOR, Journal of clinical psychopharmacology, 15(1), 1995, pp. 41-48
DETERMINATION OF MIDAZOLAM AND ITS ALPHA-HYDROXY METABOLITE IN HUMAN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
Authors: HA HR RENTSCH KM KNEER J VONDERSCHMITT DJ
Citation: Hr. Ha et al., DETERMINATION OF MIDAZOLAM AND ITS ALPHA-HYDROXY METABOLITE IN HUMAN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Therapeutic drug monitoring, 15(4), 1993, pp. 338-343
BIOAVAILABILITY AND FEASIBILITY OF SUBCUTANEOUS 5-FLUOROURACIL
Authors: BORNER MM KNEER J CREVOISIER C BRUNNER KW CERNY T
Citation: Mm. Borner et al., BIOAVAILABILITY AND FEASIBILITY OF SUBCUTANEOUS 5-FLUOROURACIL, British Journal of Cancer, 68(3), 1993, pp. 537-539
Risultati: 1-10 |